Board of Directors
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields.
Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014.
He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields.
Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014.
He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Sébastien Descarpentries joined Auriga Partners in 1999. He is a member of the Executive Board.
Before joining Auriga, Sébastien worked for 5 years, including 2 years in England, within an industrial group. He was in charge of acquisitions and prepared its IPO.
Within Auriga, Sébastien participated in the structuring of around 100 investments, 22 IPOs and 25 trade sales. He is a board member of a number of participations. He is also in charge of investor relations for the managed funds.
Sébastien is a graduate of the Institut Supérieur de Gestion.
Sébastien Descarpentries joined Auriga Partners in 1999. He is a member of the Executive Board.
Before joining Auriga, Sébastien worked for 5 years, including 2 years in England, within an industrial group. He was in charge of acquisitions and prepared its IPO.
Within Auriga, Sébastien participated in the structuring of around 100 investments, 22 IPOs and 25 trade sales. He is a board member of a number of participations. He is also in charge of investor relations for the managed funds.
Sébastien is a graduate of the Institut Supérieur de Gestion.
Alexandre Schanne has been chargé d'affaires at Odyssée Venture since 2017 and is particularly interested in the fields of healthcare, consulting and software editing.
Founded in 1999, Odyssée Venture is one of the historical actors of Private Equity in France and one of the first independent management companies of private equity funds.
It has raised more than 550 million euros and has financed over 150 French companies at various stages of development.
Alexandre Schanne has been chargé d'affaires at Odyssée Venture since 2017 and is particularly interested in the fields of healthcare, consulting and software editing.
Founded in 1999, Odyssée Venture is one of the historical actors of Private Equity in France and one of the first independent management companies of private equity funds.
It has raised more than 550 million euros and has financed over 150 French companies at various stages of development.
Pascale has nearly 25 years of professional experience in the medical device industry, having worked in major medical device groups such as Boston Scientific, Guidant-Abbott and Terumo as a team manager and member of executive committees.
She then served as Executive Director of the startup Nodea Medical for 3 years.
In 2013, strengthened by this recognized executive dimension and her expertise, she created Emergences Santé Conseil, a consulting firm specific to the healthcare industry through which she has accompanied entrepreneurs in the development of their activities.
At the same time, she was an Innovation Project Manager for the French Radiology Society, a member of the "DAS Diagnostic and Interventional Imaging" Commission of Medicen and a member of the "Medtech Diagnostics" Commission of France Biotech.
Trained in corporate coaching, conflict mediation and co-development, she now assists, through her structure Emergences-Co, executives, managers and their teams with a systemic and solution-oriented approach, to combine individual commitment with collective efficiency.
Pascale has nearly 25 years of professional experience in the medical device industry, having worked in major medical device groups such as Boston Scientific, Guidant-Abbott and Terumo as a team manager and member of executive committees.
She then served as Executive Director of the startup Nodea Medical for 3 years.
In 2013, strengthened by this recognized executive dimension and her expertise, she created Emergences Santé Conseil, a consulting firm specific to the healthcare industry through which she has accompanied entrepreneurs in the development of their activities.
At the same time, she was an Innovation Project Manager for the French Radiology Society, a member of the "DAS Diagnostic and Interventional Imaging" Commission of Medicen and a member of the "Medtech Diagnostics" Commission of France Biotech.
Trained in corporate coaching, conflict mediation and co-development, she now assists, through her structure Emergences-Co, executives, managers and their teams with a systemic and solution-oriented approach, to combine individual commitment with collective efficiency.
Scientifically trained, Arnaud has a long and rich experience in the field of medical technologies (imaging, robotics, IOT, hearing) mainly in projects based on software and artificial intelligence.
He co-founded MEDIAN Technologies (EuroNext: ALMDT) in 2002, a company specializing in diagnostic software solutions and services for medical imaging purposes (routine and clinical trials), in which he led all the stages of development until 2017.
Arnaud is an independent board member of multiple companies (Axilum Robotics followed by VitaDX and Biosency), supports high-potential innovative companies (HalioDX, KeenEye, etc.), and occasionally conducts studies and audits for venture capital funds, notably through his consulting firm Aliotis.
Since 2018, Arnaud has co-founded and is the acting CEO of Neocustic, which develops and markets innovative solutions based on connected prostheses for hearing personalization and remote audiology.
Scientifically trained, Arnaud has a long and rich experience in the field of medical technologies (imaging, robotics, IOT, hearing) mainly in projects based on software and artificial intelligence.
He co-founded MEDIAN Technologies (EuroNext: ALMDT) in 2002, a company specializing in diagnostic software solutions and services for medical imaging purposes (routine and clinical trials), in which he led all the stages of development until 2017.
Arnaud is an independent board member of multiple companies (Axilum Robotics followed by VitaDX and Biosency), supports high-potential innovative companies (HalioDX, KeenEye, etc.), and occasionally conducts studies and audits for venture capital funds, notably through his consulting firm Aliotis.
Since 2018, Arnaud has co-founded and is the acting CEO of Neocustic, which develops and markets innovative solutions based on connected prostheses for hearing personalization and remote audiology.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields.
Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014.
He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields.
Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014.
He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
After over 15 years spent in US companies of the medical device industry, Jacques Le Bozec founded and directed Vitalitec. The company was specialized in the design, development, manufacturing and commercialization of medical devices in cardiac and vascular fields. Jacques Le Bozec organized the sale of Vitalitec to Peters Surgical in 2014. He has developed an expertise in financial structuring, corporate strategies and investor relations management.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Leila NICOLAS holds a Master's degree in Cell Biology and a Master's degree in Healthcare Business Management. She has worked in marketing and business development for nearly 10 years in the pharmaceutical industry and in two life sciences start-ups. Leila joined GO Capital in 2013, where she manages healthcare investments, mainly in seed stage, in both medical technology and drug development companies.
Sébastien Descarpentries joined Auriga Partners in 1999. He is a member of the Executive Board.
Before joining Auriga, Sébastien worked for 5 years, including 2 years in England, within an industrial group. He was in charge of acquisitions and prepared its IPO.
Within Auriga, Sébastien participated in the structuring of around 100 investments, 22 IPOs and 25 trade sales. He is a board member of a number of participations. He is also in charge of investor relations for the managed funds.
Sébastien is a graduate of the Institut Supérieur de Gestion.
Sébastien Descarpentries joined Auriga Partners in 1999. He is a member of the Executive Board.
Before joining Auriga, Sébastien worked for 5 years, including 2 years in England, within an industrial group. He was in charge of acquisitions and prepared its IPO.
Within Auriga, Sébastien participated in the structuring of around 100 investments, 22 IPOs and 25 trade sales. He is a board member of a number of participations. He is also in charge of investor relations for the managed funds.
Sébastien is a graduate of the Institut Supérieur de Gestion.
Alexandre Schanne has been chargé d'affaires at Odyssée Venture since 2017 and is particularly interested in the fields of healthcare, consulting and software editing.
Founded in 1999, Odyssée Venture is one of the historical actors of Private Equity in France and one of the first independent management companies of private equity funds.
It has raised more than 550 million euros and has financed over 150 French companies at various stages of development.
Alexandre Schanne has been chargé d'affaires at Odyssée Venture since 2017 and is particularly interested in the fields of healthcare, consulting and software editing.
Founded in 1999, Odyssée Venture is one of the historical actors of Private Equity in France and one of the first independent management companies of private equity funds.
It has raised more than 550 million euros and has financed over 150 French companies at various stages of development.
Pascale has nearly 25 years of professional experience in the medical device industry, having worked in major medical device groups such as Boston Scientific, Guidant-Abbott and Terumo as a team manager and member of executive committees.
She then served as Executive Director of the startup Nodea Medical for 3 years.
In 2013, strengthened by this recognized executive dimension and her expertise, she created Emergences Santé Conseil, a consulting firm specific to the healthcare industry through which she has accompanied entrepreneurs in the development of their activities.
At the same time, she was an Innovation Project Manager for the French Radiology Society, a member of the "DAS Diagnostic and Interventional Imaging" Commission of Medicen and a member of the "Medtech Diagnostics" Commission of France Biotech.
Trained in corporate coaching, conflict mediation and co-development, she now assists, through her structure Emergences-Co, executives, managers and their teams with a systemic and solution-oriented approach, to combine individual commitment with collective efficiency.
Pascale has nearly 25 years of professional experience in the medical device industry, having worked in major medical device groups such as Boston Scientific, Guidant-Abbott and Terumo as a team manager and member of executive committees.
She then served as Executive Director of the startup Nodea Medical for 3 years.
In 2013, strengthened by this recognized executive dimension and her expertise, she created Emergences Santé Conseil, a consulting firm specific to the healthcare industry through which she has accompanied entrepreneurs in the development of their activities.
At the same time, she was an Innovation Project Manager for the French Radiology Society, a member of the "DAS Diagnostic and Interventional Imaging" Commission of Medicen and a member of the "Medtech Diagnostics" Commission of France Biotech.
Trained in corporate coaching, conflict mediation and co-development, she now assists, through her structure Emergences-Co, executives, managers and their teams with a systemic and solution-oriented approach, to combine individual commitment with collective efficiency.
Scientifically trained, Arnaud has a long and rich experience in the field of medical technologies (imaging, robotics, IOT, hearing) mainly in projects based on software and artificial intelligence.
He co-founded MEDIAN Technologies (EuroNext: ALMDT) in 2002, a company specializing in diagnostic software solutions and services for medical imaging purposes (routine and clinical trials), in which he led all the stages of development until 2017.
Arnaud is an independent board member of multiple companies (Axilum Robotics followed by VitaDX and Biosency), supports high-potential innovative companies (HalioDX, KeenEye, etc.), and occasionally conducts studies and audits for venture capital funds, notably through his consulting firm Aliotis.
Since 2018, Arnaud has co-founded and is the acting CEO of Neocustic, which develops and markets innovative solutions based on connected prostheses for hearing personalization and remote audiology.
Scientifically trained, Arnaud has a long and rich experience in the field of medical technologies (imaging, robotics, IOT, hearing) mainly in projects based on software and artificial intelligence.
He co-founded MEDIAN Technologies (EuroNext: ALMDT) in 2002, a company specializing in diagnostic software solutions and services for medical imaging purposes (routine and clinical trials), in which he led all the stages of development until 2017.
Arnaud is an independent board member of multiple companies (Axilum Robotics followed by VitaDX and Biosency), supports high-potential innovative companies (HalioDX, KeenEye, etc.), and occasionally conducts studies and audits for venture capital funds, notably through his consulting firm Aliotis.
Since 2018, Arnaud has co-founded and is the acting CEO of Neocustic, which develops and markets innovative solutions based on connected prostheses for hearing personalization and remote audiology.
- VitaDX raised €1.2 million in July 2015 from 28 individual French shareholders as well as a Singaporean and an American for investments between 10 and €30k.
- In June 2017, VitaDX completed a second fundraising of €1.5 million from two investment funds Go Capital and Auriga Partners and two private investors.
- In 2019-2020, VitaDX raised €5 million from the historical venture capital funds Go Capital, Auriga Partners, FFBB Management and also from a new fund Odyssee Venture to support the finalization of VisioCyt®.